Security key
00973N102
Aktis Oncology, Inc. - Common Stock, par value $0.0001 per share (AKTSQ)
CUSIP: 00973N102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 53,401,149
- Total 13F shares
- 22,552,604
- Share change
- -17,855,016
- Total reported value
- $2,969,307
- Put/Call ratio
- 1.2%
- Price per share
- $0.13
- Number of holders
- 86
- Value change
- -$6,536,132
- Number of buys
- 35
- Number of sells
- 78
Report period
Q2 2024
Institutions
86
Top holders
10
AKTSQ full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Aktis Oncology, Inc. SEC filings
Aktis Oncology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00973N102
Recent filing periods:
Top shareholders of AKTSQ - Aktis Oncology, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
10%
|
5,604,333
|
$3,312,721 | — | 31 Mar 2024 | |
| HERALD INVESTMENT MANAGEMENT Ltd |
13F
|
Company |
8.1%
|
4,303,636
|
$2,532,259 | — | 31 Mar 2024 | |
| SILVERBACK ASSET MANAGEMENT LLC |
13F
|
Company |
7.9%
|
4,238,389
|
$2,505,312 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.2%
|
3,824,953
|
$2,260,929 | — | 31 Mar 2024 | |
| Taylor Frigon Capital Management LLC |
13F
|
Company |
6.3%
|
3,358,195
|
$1,985,029 | — | 31 Mar 2024 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
4.5%
|
2,405,152
|
$1,422,000 | — | 31 Mar 2024 | |
| Senvest Management, LLC |
13F
|
Company |
4.1%
|
2,196,577
|
$1,298,397 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.9%
|
2,099,504
|
$1,241,121 | — | 31 Mar 2024 | |
| Sargent Investment Group, LLC |
13F
|
Company |
3.1%
|
1,671,150
|
$987,817 | — | 31 Mar 2024 | |
| AWM Investment Company, Inc. |
13F
|
Company |
2.9%
|
1,537,008
|
$908,525 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
1,260,437
|
$745,044 | — | 31 Mar 2024 | |
| West Tower Group, LLC |
13F
|
Company |
1.7%
|
882,407
|
$521,591 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.6%
|
833,113
|
$492,453 | — | 31 Mar 2024 | |
| 272 Capital LP |
13F
|
Company |
1.4%
|
745,452
|
$440,637 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.87%
|
465,649
|
$275,199 | — | 31 Mar 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.74%
|
395,784
|
$233,948 | — | 31 Mar 2024 | |
| FRG Family Wealth Advisors LLC |
13F
|
Company |
0.65%
|
346,697
|
$203,546 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.64%
|
342,235
|
$202,000 | — | 31 Mar 2024 | |
| AMH Equity Ltd |
13F
|
Company |
0.47%
|
250,000
|
$147,775 | — | 31 Mar 2024 | |
| Creative Planning |
13F
|
Company |
0.46%
|
244,319
|
$144,417 | — | 31 Mar 2024 | |
| MISSION WEALTH MANAGEMENT, LP |
13F
|
Company |
0.42%
|
226,819
|
$134,074 | — | 31 Mar 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.42%
|
223,300
|
$132,000 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.4%
|
213,442
|
$126,166 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.37%
|
198,871
|
$117,553 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.33%
|
174,053
|
$102,883 | — | 31 Mar 2024 | |
| Adalta Capital Management LLC |
13F
|
Company |
0.3%
|
160,000
|
$94,576 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.28%
|
149,599
|
$88,428 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.25%
|
131,249
|
$77,568 | — | 31 Mar 2024 | |
| OPPENHEIMER & CO INC |
13F
|
Company |
0.2%
|
106,770
|
$63,112 | — | 31 Mar 2024 | |
| Raymond James Financial Services Advisors, Inc. |
13F
|
Company |
0.2%
|
105,908
|
$62,602 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.18%
|
94,381
|
$55,789 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.17%
|
92,635
|
$54,737 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.17%
|
91,819
|
$54,173 | — | 31 Mar 2024 | |
| Gibbs Wealth Management |
13F
|
Company |
0.15%
|
82,467
|
$48,746 | — | 31 Mar 2024 | |
| TOWNSQUARE CAPITAL LLC |
13F
|
Company |
0.15%
|
82,467
|
$48,746 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.15%
|
82,295
|
$48,645 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.13%
|
68,402
|
$40,432 | — | 31 Mar 2024 | |
| Crestwood Advisors Group, LLC |
13F
|
Company |
0.13%
|
67,537
|
$39,921 | — | 31 Mar 2024 | |
| CONNORS INVESTOR SERVICES INC |
13F
|
Company |
0.12%
|
65,000
|
$38,422 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.12%
|
63,030
|
$37,257 | — | 31 Mar 2024 | |
| MARATHON CAPITAL MANAGEMENT |
13F
|
Company |
0.1%
|
55,600
|
$32,865 | — | 31 Mar 2024 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.09%
|
46,965
|
$27,761 | — | 31 Mar 2024 | |
| Atria Wealth Solutions, Inc. |
13F
|
Company |
0.09%
|
46,500
|
$27,486 | — | 31 Mar 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.09%
|
45,980
|
$27,179 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.08%
|
42,588
|
$25,174 | — | 31 Mar 2024 | |
| GRIFFIN ASSET MANAGEMENT, INC. |
13F
|
Company |
0.07%
|
40,000
|
$23,644 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.07%
|
38,989
|
$23,046 | — | 31 Mar 2024 | |
| HBK Sorce Advisory LLC |
13F
|
Company |
0.07%
|
38,911
|
$23,001 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.07%
|
38,111
|
$22,527 | — | 31 Mar 2024 | |
| HoyleCohen, LLC |
13F
|
Company |
0.07%
|
36,502
|
$21,577 | — | 31 Mar 2024 |
Institutional Holders of Aktis Oncology, Inc. - Common Stock, par value $0.0001 per share (AKTSQ) as of Q2 2024
As of 30 Jun 2024,
Aktis Oncology, Inc. - Common Stock, par value $0.0001 per share (AKTSQ) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,552,604 shares.
The largest 10 holders included
VANGUARD GROUP INC, Taylor Frigon Capital Management LLC, SILVERBACK ASSET MANAGEMENT LLC, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC), Senvest Management, LLC, BlackRock Inc., PERKINS CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, Sargent Investment Group, LLC, and NORTHERN TRUST CORP.
This page lists
87
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
114
Q2 2024 holders
86
Holder diff
-28
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.